Literature DB >> 23487384

Candida glabrata and FKS mutations: witnessing the emergence of the true multidrug-resistant Candida.

Luis Ostrosky-Zeichner.   

Abstract

Entities:  

Keywords:  Candida glabrata; FKS mutation; echinocandins; multidrug-resistant Candida

Mesh：

Substances：

Year:  2013        PMID： 23487384     DOI： 10.1093/cid/cit140

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  16 in total

1.  Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates.

Authors:  Mariana Castanheira; Leah N Woosley; Shawn A Messer; Daniel J Diekema; Ronald N Jones; Michael A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

Review 2.  What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients.

Authors:  Cristóbal León; Luis Ostrosky-Zeichner; Mindy Schuster
Journal:  Intensive Care Med       Date:  2014-04-10       Impact factor: 17.440

3.  Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes.

Authors:  Shaoming Lin; Ruilan Chen; Song Zhu; Huijun Wang; Lianfang Wang; Jian Zou; Jingdong Yan; Xiangdong Zhang; Dimitrios Farmakiotis; Xiaojiang Tan; Eleftherios Mylonakis
Journal:  Mycopathologia       Date:  2018-03-23       Impact factor: 2.574

4.  Antifungal Activity of the Noncytotoxic Human Peptide Hepcidin 20 against Fluconazole-Resistant Candida glabrata in Human Vaginal Fluid.

Authors:  Gaetano Del Gaudio; Lisa Lombardi; Giuseppantonio Maisetta; Semih Esin; Giovanna Batoni; Maurizio Sanguinetti; Sonia Senesi; Arianna Tavanti
Journal:  Antimicrob Agents Chemother       Date:  2013-06-24       Impact factor: 5.191

5.  In vitro antifungal susceptibility of Candida glabrata to caspofungin and the presence of FKS mutations correlate with treatment response in an immunocompromised murine model of invasive infection.

Authors:  Fabiola Fernández-Silva; Michaela Lackner; Javier Capilla; Emilio Mayayo; Deanna Sutton; Mariana Castanheira; Annette W Fothergill; Cornelia Lass-Flörl; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

6.  Drug-resistant Candida glabrata infection in cancer patients.

Authors:  Dimitrios Farmakiotis; Jeffrey J Tarrand; Dimitrios P Kontoyiannis
Journal:  Emerg Infect Dis       Date:  2014-11       Impact factor: 6.883

7.  Heteroresistance to Fluconazole Is a Continuously Distributed Phenotype among Candida glabrata Clinical Strains Associated with In Vivo Persistence.

Authors:  Ronen Ben-Ami; Offer Zimmerman; Talya Finn; Sharon Amit; Anna Novikov; Noa Wertheimer; Mor Lurie-Weinberger; Judith Berman
Journal:  MBio       Date:  2016-08-02       Impact factor: 7.867

8.  Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults.

Authors:  Taylor Sandison; Voon Ong; Jonathan Lee; Dirk Thye
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

9.  De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety.

Authors:  Karim Jaffal; Julien Poissy; Anahita Rouze; Sébastien Preau; Boualem Sendid; Marjorie Cornu; Saad Nseir
Journal:  Ann Intensive Care       Date:  2018-04-19       Impact factor: 6.925

Review 10.  Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?

Authors:  Vasiliki Soulountsi; Theodoros Schizodimos; Serafeim Chrysovalantis Kotoulas
Journal:  Infection       Date:  2021-06-16       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.